Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial"

Jesper Jensen; Massar Omar; Jacob Eifer Møller; Morten Schou

doi:10.1016/j.ahj.2021.02.007

Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial"

Jesper Jensen, Massar Omar, Jacob Eifer Møller, Morten Schou

Hjertesygdomme

Originalsprog	Engelsk
Tidsskrift	American Heart Journal
Vol/bind	236
Sider (fra-til)	106
ISSN	0002-8703
DOI	https://doi.org/10.1016/j.ahj.2021.02.007
Status	Udgivet - jun. 2021

Adgang til dokumentet

10.1016/j.ahj.2021.02.007

Andre filer og links

Link to publication in Scopus

Citationsformater

Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial". / Jensen, Jesper; Omar, Massar; Møller, Jacob Eifer et al.
I: American Heart Journal, Bind 236, 06.2021, s. 106.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

@article{7953c736b1dd41caa948b7ffabdb9b3d,

title = "Response to Patoulias et al. letter regarding article {"}Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial{"}",

keywords = "Benzhydryl Compounds/therapeutic use, Glucosides, Heart Failure/drug therapy, Humans",

author = "Jesper Jensen and Massar Omar and M{\o}ller, {Jacob Eifer} and Morten Schou",

year = "2021",

month = jun,

doi = "10.1016/j.ahj.2021.02.007",

language = "English",

volume = "236",

pages = "106",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction

T2 - A double-blinded, randomized, and placebo-controlled trial"

AU - Jensen, Jesper

AU - Omar, Massar

AU - Møller, Jacob Eifer

AU - Schou, Morten

PY - 2021/6

Y1 - 2021/6

KW - Benzhydryl Compounds/therapeutic use

KW - Glucosides

KW - Heart Failure/drug therapy

KW - Humans

UR - http://www.scopus.com/inward/record.url?scp=85104677699&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2021.02.007

DO - 10.1016/j.ahj.2021.02.007

M3 - Comment/debate

C2 - 33902821

SN - 0002-8703

VL - 236

SP - 106

JO - American Heart Journal

JF - American Heart Journal

ER -